What is the current price and volume for ALNA stock in pre-market?

ALNA stock is quoted at **$0.075** in pre-market with volume of **252,311,606** shares; intraday range today moved between **$0.06** and **$0.1459** on NASDAQ.

What grade does Meyka AI assign to ALNA and what does it mean?

Meyka AI rates ALNA **62.67 (B)** with a suggestion to **HOLD**. The grade combines benchmark, sector, financial growth, key metrics and analyst signals; it is informational and not investment advice.

What are realistic short-term price targets for ALNA stock?

Short-term tactical targets we track are a downside support near **$0.05** and an upside target near **$0.15**. Meyka AI model projects **$0.12**, implying about **60.00%** upside from **$0.075**.

What are the main risks for traders in ALNA stock?

Key risks include clinical-stage binary events, negative earnings (EPS **-0.638**), thin or unclear float data, and wide intraday volatility that can widen bid-ask spreads on NASDAQ.

US Stocks

Pre-Market Most Active: ALNA Allena Pharmaceuticals (NASDAQ) $0.075 05 Mar 2026: volume alert

ByDanny Kontos March 5, 2026

ALNA stock is trading at $0.075 in the pre-market on NASDAQ as heavy volume of 252,311,606 shares signals unusually active trading. The stock is up 3.16% versus the previous close of $0.0727, with a pre-market range between $0.06 and $0.1459. Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) is a U.S. biotechnology company focused on oral enzyme therapeutics, led by its ALLN-346 program for gout in chronic kidney disease. We summarize why ALNA stock is one of the most active names this pre-market and what traders should watch next.